Acceleware has announced that its multi-core CT image reconstruction solution, AxRecon, was adopted by the major pharmaceutical company Eli Lilly.
Our early success in helping pharmaceutical companies reduce time spent in drug development is encouraging,” said Sean Krakiwsky, CEO of Acceleware
Corp. “AxRecon’s ability to simply and seamlessly fit with existing CT scanner hardware and software to deliver results up to 50 times faster makes our product attractive to medical researchers and other users of CT Scanners.”
Acceleware’s application acceleration solution(s) utilize the ever present NVIDIA GPU compute platform.
For more info, read the full release.
Leave your own comment